The Use of Faecal Calprotectin in Primary Care

Slides:



Advertisements
Similar presentations
Diagnostic Work-up. There is no specific laboratory or imaging test to diagnose irritable bowel syndrome. Currently the diagnosis of IBS relies on meeting.
Advertisements

Irritable bowel syndrome in adults
Irritable Bowel Syndrome Dr Bruce Davies Sept 2001Bruce Davies2 Introduction First described in % of patients present
One-stop dyspepsia clinic
Faecal Calprotectin is a Cost-Effective Method of Assessing Activity of Inflammatory Bowel Disease A D Dhanda 1, P MacMillan 1, N Eastley 1, J Wassell.
Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
Diagnostic Accuracy of Point-of-Care Fecal Calprotectin and Immunochemical Occult Blood Tests for Diagnosis of Organic Bowel Disease in Primary Care: The.
IBS or IBD: a N.I.C.E. Way to Tell
Colorectal Cancer Screening John Pelzel MD Sleepy Eye Medical Center.
Irritable Bowel Syndrome Sam Thomson 3 rd November 2010.
Management of irritable bowel syndrome (IBS) WORKSHOP Dimitris Karanasios.
Inflammatory Bowel Disease
Ian Arnott Consultant Gastroenterologist Western General Hospital Edinburgh The Use of Faecal Calprotectin in Primary Care.
Irritable Bowel Syndrome 1481 Nadeem Khan March 2, 2015.
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
Iron deficiency anaemia Christian Selinger Consultant Gastroenterologist.
NICE guidelines: Management of dyspepsia in adults in primary care
Direct Access Flexible Sigmoidoscopy
Fecal calprotectin DR Amin Eftekhari.
Diagnostic accuracy systematic review of rectal bleeding in combination with other symptoms, signs and tests in relation to colorectal cancer Olde Bekkink.
MARK COLEMAN MBChB FRCS (Gen Surg) MD hon FRCPSG Consultant Colorectal Surgeon
The Use of a Faecal Calprotectin Service in Routine Practice Can Help in Clinical Dilemma and Significantly Reduce Unnecessary Colonoscopy. M. W. Johnson,
Suspected cancer: recognition and referral NICE guidelines [NG12] Published date: June 2015 also cancer researchuk Dr Jane Wilcock.
Are patients with chronic diseases a new challenge to general practice? Patients with irritable bowel syndrome in general practice Patients with irritable.
Update The 2 week rule for colorectal cancer Mr Iain Jourdan MS FRCS Director of Surgery Royal Surrey County Hospital.
Early Diagnosis of Gynaecological Cancer Rob Gornall Consultant Gynaecology GHNHST.
FIT Programme (Faecal Immunohistochemical Test)
The Use of Faecal Calprotectin in Primary Care
Seema Jain and Kristen Lewis MD
CRC 101; Part One Julie Banahan, RN, BSN, OCN
Upper Gastrointestinal Cancers Top ⑩ Tips
CRC 101; Part One Julie Banahan, RN, BSN, OCN
Camden Two Week Wait Referrals Feedback
New diabetes diagnosis pathway PLIG, 19th Jan 2017
Catriona Clark and Clare MacRae
Presenting with IBS symptoms, baseline assessment.
Irritable Bowel Syndrome (IBS)
IRRITABLE BOWEL SYNDROME
Recognition and Referral of Suspected cancer NICE NG12 – 2Week Wait
iPad Instructions iPad Instructions Polling Question.
distinguishing IBD versus D-IBS.
IRRITABLE BOWEL SYNDROME
Millie D. Long, Bruce E. Sands 
Differential Diagnosis
Diagnosis of celiac sprue
What to look out for and why?
Barts Health Trust 2WW Colorectal Workshop Dr Angela Wong,
Dr Rob Palmer – CCG Gastro Lead
Rome IV: What Has Changed? Rome IV IBS Subtypes.
AAMC CCN Colorectal Cancer Screening Integrated Care Pathway
Colorectal Cancer Cancer Alliance Work
New diabetes diagnosis pathway PLIG, 19th Jan 2017
Diagnosing Iron Deficiency Anaemia in Primary Care
Individual patients’ FCP (μg/g) values (n=119).
Distinguishing organic disease versus D-IBS.
Dr Constantinos Koshiaris
Catriona Clark and Clare MacRae
FIT for symptomatic patients
Area under the receiver operating curve showing 0
Area under the receiver operating curve showing 0
Area under the receiver operating curve showing 0
Area under the receiver operating curve showing 0
Colorectal and General Surgical Topics Relevant to GPs GP update meeting Addington Practice Tuesday 26th March 2014 Mr Steve Warren.
Northern Cancer Alliance Colorectal Symptoms Assessment Pathway
Suspected Gynaecological Cancer Recognition & Referral
Colorectal 2 week wait pathways and “Getting FIT”
NCA Colorectal Symptoms Assessment Pathway for Primary Care
Northern Cancer Alliance Colorectal Symptoms Assessment Pathway Guidance for investigating colorectal symptoms in primary care including IDA , Faecal.
Faecal Immunochemistry Test - qFIT
Receiver operating curve for faecal calprotectin in detecting patients with colorectal neoplasia (carcinoma and adenoma). Receiver operating curve for.
Presentation transcript:

The Use of Faecal Calprotectin in Primary Care Ian Arnott Consultant Gastroenterologist Western General Hospital Edinburgh

MH 30 years female 3/12 history of abdominal pain Right sided Constipation – BOx1/week No weight loss, appetite unchanged No past medical history Non-smoker

Investigations Full blood count Hb 127 WCC 7.9 Plt 293 USS normal

Impression “... I think the most likely diagnosis is constipation predominant irritable bowel syndrome. I would suggest a trial of laxatives...” Ian Arnott BUT Faecal calprotectin >2500g/g

Colonoscopy

Difficult to differentiate organic from functional symptoms IBD more common Up to 2% of population in high areas

Delay in diagnosis of IBD is important

Colonoscopy Key diagnostic tool Colorectal cancer Inflammatory bowel disease Etc etc... BUT patients with IBS do not always need this Unpleasant Reinforce doubt about diagnosis Resource intensive

Faecal calprotectin

Faecal Calprotectin: IBD v IBS Henderson et al. AJG 2014

Organic v IBS

Organic v IBS Cut off <50µg/g Cut off <100µg/g Sensitivity 99% Specificity 74% Cut off <100µg/g Sensitivity 94% Specificity 82%

Durham Dales Primary Care Pilot 6.3% prevalence of IBD 25% of presenting patients are referred FC testing saved 129 referrals Greater satisfaction for patients Approval from GPs

Gastroenterology in Lothian 1 in 10 consultations in primary care Referrals in Lothian July 13 – June 14 Total 7898 WGH 3379 RIE 3325 St John’s 1126

NICE Guidance Recommended in children and adults IBD v IBS in those with lower GI symptoms, if: Cancer not suspected Appropriate Quality assurance

Cost Effectiveness NICE estimates – most conservative FC assay costs £22 Colonoscopy £741 Compared with current practice FC saves £82 – 240 per patient seen

FC Experience in Lothian Kennedy NA et al, JCC 2014

Faecal calprotectin: Results Functional v other GI conditions Sensitivity 89% Negative predictive value 93% Functional v IBD Sensitivity 99% NPV 100%

FC together with Alarm Symptoms

Calprotectin: Who to test

FC algorithm

Lothian Algorithm - Pilot no Age less than 50? Consider referral as per current guidance yes Alarm symptoms? Referral for urgent investigation Faecal calprotectin, Stool culture, Coeliac screen & FBC Referral for D2 bx or other investigation FC 50 - 150 FC<50 FC >150 Repeat calprotectin in 4 – 6 weeks. Functional diagnosis likely Functional diagnosis Referral for investigation

Conclusions Faecal calprotectin can effectively differentiate between IBS and organic GI conditions Simple to assay Helps select patients for referral or investigation Cost effective Pilot in Lothian planned – please take part! ian.arnott@luht.scot.nhs.uk